Predictors of Relapse to Alcohol and Substance Use: Are There Any Differences between 3 and 12 Months after Inpatient Treatment?

被引:15
|
作者
Guliyev, Cavid [1 ]
Ince-Guliyev, Ezgi [2 ]
Ogel, Kultegin [1 ]
机构
[1] Moodist Hosp, Alcohol & Subst Treatment Ctr, Acibadem Mah Cecen Sk 52 Uskudar, Istanbul, Turkey
[2] Van Res & Training Hosp, Dept Psychiat, Van, Turkey
关键词
Relapse; substance use; motivation; addiction; treatment; RESIDENTIAL-TREATMENT PROGRAMS; DRUG-USERS; FOLLOW-UP; COCAINE RELAPSE; HEROIN DEPENDENCE; USE OUTCOMES; MOTIVATION; ADDICTION; ABUSE; INDIVIDUALS;
D O I
10.1080/02791072.2021.1976887
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Understanding the factors that lead to relapse is important for developing effective treatment strategies. The aim of this study is to examine sociodemographic and clinical factors that predict relapse 3 and 12 months after inpatient treatment in patients with alcohol and substance use disorders. 247 patients were included in the study. A sociodemographic data form and the Addiction Profile Index-Clinical Form (API-C) were filled out during the first days of hospitalization and relapse information was obtained through outpatient interviews. Logistic regression analysis was used to assess predictive factors. Rates of relapse for the 3(rd) and 12(th) months were 40.5% and 74.6%, respectively. Motivation to quit substance use, risk of depression, being on probation, and being employed predicted relapse within the 3-month period. At the 12(th) month, substance use intensity and motivation to quit were the factors associated with relapse. To conclude, motivation to quit is critical to maintaining both early and sustained remission. Moreover, divergent factors may be relevant at different stages of treatment. Defining relapse predictors early in the process and being vigilant to the change in the needs of patients as the treatment continues may help to develop a more effective and focused treatment plan.
引用
收藏
页码:358 / 367
页数:10
相关论文
共 50 条
  • [1] Predictors of Relapse to Any Alcohol Use After Liver Transplantation: Utility of the Alcohol Relapse Risk Assessment
    Rodrigue, J. R.
    Ghaziani, T.
    Hanto, D. W.
    Curry, M. P.
    TRANSPLANTATION, 2012, 94 (10) : 52 - 52
  • [2] Gender differences in alcohol and substance use relapse
    Walitzer, KS
    Dearing, RL
    CLINICAL PSYCHOLOGY REVIEW, 2006, 26 (02) : 128 - 148
  • [3] Substance Abuse Treatment and Its Association With Relapse to Alcohol Use After Liver Transplantation
    Rodrigue, James R.
    Hanto, Douglas W.
    Curry, Michael P.
    LIVER TRANSPLANTATION, 2013, 19 (12) : 1387 - 1395
  • [4] Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India
    Ghosh, Abhishek
    Sharma, Nidhi
    Noble, Dalton
    Basu, Debasish
    Mattoo, S. K.
    Nanjayaya, Subodh B.
    Pillai, R. R.
    Kaur, Simranjit
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (02) : E101 - E109
  • [5] Predictors of relapse after treatment for methamphetamine use
    Brecht, ML
    von Mayrhauser, C
    Anglin, MD
    JOURNAL OF PSYCHOACTIVE DRUGS, 2000, 32 (02) : 211 - 220
  • [6] Psychiatric, Demographic, and Brain Morphological Predictors of Relapse After Treatment for an Alcohol Use Disorder
    Durazzo, Timothy C.
    Meyerhoff, Dieter J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 (01) : 107 - 116
  • [7] Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland
    Buri, Caroline
    Moggi, Franz
    Giovanoli, Anna
    Strik, Werner
    ALCOHOL AND ALCOHOLISM, 2007, 42 (04): : 333 - 339
  • [8] Association Between Alcohol, Substance Use, and Inpatient Burn Outcomes
    Williams, Felicia N.
    Chrisco, Lori
    Strassle, Paula D.
    Navajas, Emma
    Laughon, Sarah L.
    Sljivic, Sanja
    Nizamani, Rabia
    Charles, Anthony
    King, Booker
    JOURNAL OF BURN CARE & RESEARCH, 2021, 42 (04): : 595 - 599
  • [9] Relapse after inpatient substance use treatment: A prospective cohort study among users of illicit substances
    Andersson, Helle Wessel
    Wenaas, Merethe
    Nordfjaern, Trond
    ADDICTIVE BEHAVIORS, 2019, 90 : 222 - 228
  • [10] Predictors of response to erenumab after 12 months of treatment
    Baraldi, Carlo
    Lo Castro, Flavia
    Cainazzo, Maria Michela
    Pani, Luca
    Guerzoni, Simona
    BRAIN AND BEHAVIOR, 2021, 11 (08):